![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
(51) | INT.CL. | A61K 31/704 | (2006.01) |
A61K 45/06 | (2013.01) | ||
A61K 31/702 | (2006.01) | ||
A61K 31/704 | (2013.01) | ||
A61K 31/573 | (2006.01) | ||
A61P 35/00 | (2018.01) | ||
A61K 39/395 | (2006.01) | ||
A61K 39/3955 | (2013.01) | ||
A61P 35/00 | (2006.01) | ||
C07K 16/2818 | (2013.01) | ||
A61K2039/505 | (2013.01) | ||
C07K2317/76 | (2013.01) |
(11) | Patento numeris | 3554511 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 17880962.0 |
Europos patento paraiškos padavimo data | 2017-12-15 | |
(97) | Europos patento paraiškos paskelbimo data | 2019-10-23 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2024-07-10 |
(46) | Apibrėžties vertimo paskelbimo data |
(86) | Numeris | PCT/AU2017/051402 |
Data | 2017-12-15 |
(87) | Numeris | WO 2018/107244 |
Data | 2018-06-21 |
(30) | Numeris | Data | Šalis |
2016905199 | 2016-12-15 | AU |
(72) |
DREDGE, Keith , AU
|
(73) |
Progen PG500 Series Pty Ltd ,
184 Moorabool Street, Geelong, Victoria 3220,
AU
|
(54) | COMBINATION OF AN IMMUNE CHECKPOINT INHIBITOR PD-1 OR PD-L1 INHIBITOR WITH AN HEPARAN SULFATE MIMETIC AND THE USE THEREOF IN THE TREATMENT OR PREVENTION OF CANCER |
COMBINATION OF AN IMMUNE CHECKPOINT INHIBITOR PD-1 OR PD-L1 INHIBITOR WITH AN HEPARAN SULFATE MIMETIC AND THE USE THEREOF IN THE TREATMENT OR PREVENTION OF CANCER |